45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
9,560
Insurances with rates
19
CPT / HCPCS codes
5,516
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| Q2042 | TISAGENLECLEUCEL 250000000 CELLS SUSP 1 EACH FLEX CONT | $2,991,408 | $1,196,563 | — | — | 17 |
| Q2056 | CILTACABTAGENE AUTOLEUCEL 100000000 CELLS SUSP 1 EACH FLEX CONT | $2,798,765 | $1,119,506 | — | — | 17 |
| Q2054 | LISOCABTAGENE MARALEUCEL 70000000 CELLS/ML SUSP 1 EACH BOX | $2,678,006 | $1,071,202 | — | — | 17 |
| Q2055 | IDECABTAGENE VICLEUCEL 460000000 CELLS SUSP 1 EACH FLEX CONT | $2,662,695 | $1,065,078 | — | — | 17 |
| Q2041 | AXICABTAGENE CILOLEUCEL 200000000 CELLS SUSP 1 EACH PACKAGE | $2,538,043 | $1,015,217 | — | — | 17 |
| Q2053 | BREXUCABTAGENE AUTOLEUCEL 200000000 CELLS SUSP 1 EACH FLEX CONT | $2,328,480 | $931,392 | — | — | 17 |
| BREXUCABTAGENE AUTOLEUCEL 100000000 CELLS SUSP 1 | BREXUCABTAGENE AUTOLEUCEL 100000000 CELLS SUSP 1 EACH FLEX CONT | $2,328,480 | $931,392 | — | — | 6 |
| J2326 | NUSINERSEN 12 MG/5ML SOLN 5 ML VIAL | $737,347 | $294,939 | — | — | 19 |
| J0225 | VUTRISIRAN SODIUM 25 MG/0.5ML SOSY 0.5 ML SYRINGE | $601,529 | $240,612 | — | — | 19 |
| Q2043 | SIPULEUCEL-T 50000000 CELLS SUSP 250 ML FLEX CONT | $345,566 | $138,226 | — | — | 19 |
| VAD VENTRICAL ASSIST DEVICE | VAD VENTRICAL ASSIST DEVICE | $244,908 | $97,963 | — | — | 8 |
| J1823 | INEBILIZUMAB-CDON 100 MG/10ML SOLN 10 ML VIAL | $235,617 | $94,247 | — | — | 19 |
| J0223 | GIVOSIRAN SODIUM 189 MG/ML SOLN 1 ML VIAL | $221,226 | $88,490 | — | — | 13 |
| J2351 | OCRELIZUMAB-HYALURONIDASE-OCSQ 920-23000 MG-UT/23ML SOLN 23 ML VIAL | $218,880 | $87,552 | — | — | 18 |
| C9293 | GLUCARPIDASE 1000 UNITS SOLR 1 EACH VIAL | $217,894 | $87,158 | — | — | 11 |
| J9228 | IPILIMUMAB 200 MG/40ML SOLN 40 ML VIAL | $186,194 | $74,478 | — | — | 19 |
| J9269 | TAGRAXOFUSP-ERZS 1000 MCG/ML SOLN 1 ML VIAL | $170,134 | $68,053 | — | — | 19 |
| J9118 | CALASPARGASE PEGOL-MKNL 3750 UNIT/5ML SOLN 5 ML VIAL | $150,001 | $60,000 | — | — | 11 |
| J0202 | ALEMTUZUMAB 12 MG/1.2ML SOLN 1.2 ML VIAL | $149,911 | $59,964 | — | — | 19 |
| J9359 | LONCASTUXIMAB TESIRINE-LPYL 10 MG SOLR 1 EACH VIAL | $146,310 | $58,524 | — | — | 19 |
| 90288 | BOTULISM IMMUNE GLOBULIN HUMAN 100 MG SOLR 1 EACH VIAL | $145,530 | $58,212 | — | — | 7 |
| J1951 | LEUPROLIDE ACETATE (PED)(6MON) 45 MG KIT 1 EACH BOX | $145,229 | $58,091 | — | — | 57 |
| J9266 | PEGASPARGASE 750 UNIT/ML SOLN 5 ML VIAL | $138,527 | $55,411 | — | — | 19 |
| J9348 | NAXITAMAB-GQGK 40 MG/10ML SOLN 10 ML VIAL | $131,372 | $52,549 | — | — | 13 |
| RIBAVIRIN 6 G SOLR 1 EACH VIAL | RIBAVIRIN 6 G SOLR 1 EACH VIAL | $125,805 | $50,322 | — | — | 8 |
| J1303 | RAVULIZUMAB-CWVZ 1100 MG/11ML SOLN 11 ML VIAL | $123,731 | $49,492 | — | — | 19 |
| J9229 | INOTUZUMAB OZOGAMICIN 0.9 MG SOLR 1 EACH VIAL | $122,947 | $49,179 | — | — | 19 |
| J9600 | PORFIMER 75 MG SOLR 1 EACH VIAL | $117,548 | $47,019 | — | — | 13 |
| J3316 | TRIPTORELIN PAMOATE ER (CPP) 22.5 MG SRER 1 EACH VIAL | $115,752 | $46,301 | — | — | 19 |
| J2502 | PASIREOTIDE PAMOATE 10 MG SRER 1 EACH VIAL | $109,665 | $43,866 | — | — | 19 |
| J2350 | OCRELIZUMAB 300 MG/10ML SOLN 10 ML VIAL | $109,440 | $43,776 | — | — | 19 |
| J9274 | TEBENTAFUSP-TEBN 100 MCG/0.5ML SOLN 0.5 ML VIAL | $108,410 | $43,364 | — | — | 19 |
| J9309 | POLATUZUMAB VEDOTIN-PIIQ 140 MG SOLR 1 EACH VIAL | $99,430 | $39,772 | — | — | 19 |
| J9210 | EMAPALUMAB-LZSG 50 MG/10ML SOLN 10 ML VIAL | $93,517 | $37,407 | — | — | 19 |
| J3241 | TEPROTUMUMAB-TRBW 500 MG SOLR 1 EACH VIAL | $90,816 | $36,326 | — | — | 19 |
| J3245 | TILDRAKIZUMAB-ASMN 100 MG/ML SOSY 1 ML SYRINGE | $90,526 | $36,210 | — | — | 19 |
| L8690 | AUD OSSEO DEV INT/EXT COMP | $88,550 | $35,420 | — | — | 8 |
| C1825 | GENERATOR NEUROSTIM BAROSTIM NEO LEGACY | $87,500 | $35,000 | — | — | 8 |
| 33270 | 33270 INSERTION OR REPLACEMENT OF DEFIBRILLATOR WITH ELECTRODE | $86,240 | $34,496 | — | — | 19 |
| J7330 | AUTOLOGOUS CULTURED CHONDROCYTES IMPLANT | $84,000 | $33,600 | — | — | 9 |
| 0915T | INSJ PERM CCM-D SYS PGANDELTRD | $80,154 | $32,062 | — | — | 13 |
| J9298 | NIVOLUMAB-RELATLIMAB-RMBW 240-80 MG/20ML SOLN 20 ML VIAL | $79,281 | $31,713 | — | — | 19 |
| J3357 | USTEKINUMAB 45 MG/0.5ML SOSY 0.5 ML SYRINGE | $77,135 | $30,854 | — | — | 15 |
| J1304 | TOFERSEN 100 MG/15ML SOLN 15 ML VIAL | $76,087 | $30,435 | — | — | 19 |
| 64582 | OPEN IMPLTJ HPGLSL NRV NSTIM RA PGANDRESPIR SENSOR | $75,159 | $30,064 | — | — | 19 |
| J1628 | GUSELKUMAB 100 MG/ML SOAJ 1 ML PEN | $73,415 | $29,366 | — | — | 19 |
| J9043 | CABAZITAXEL 60 MG/1.5ML SOLN 6 ML VIAL | $71,299 | $28,519 | — | — | 19 |
| TELISOTUZUMAB VEDOTIN-TLLV 100 MG SOLR 1 EACH VI | TELISOTUZUMAB VEDOTIN-TLLV 100 MG SOLR 1 EACH VIAL | $70,459 | $28,184 | — | — | 6 |
| AQUISTION FEES | AQUISTION FEES | $70,000 | $28,000 | — | — | 6 |
| 0620T | ENDOVASCULAR VENOUS ARTERIALIZATION TIBL/PRNL VN | $68,751 | $27,500 | — | — | 12 |
Showing top 50 of 9,560 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.